Yiwen Chen

机构：Shanghai Clinical Research Center, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0003-4525-0954

发表论文 11 篇 · 总被引 140 次 · h-index 3

代表论文

• Oncolytic virus VG161 in refractory hepatocellular carcinoma (2025 · Nature · 被引 82)
• Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial (2025 · Hepatology · 被引 28)
• Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial (2023 · Hepatology Communications · 被引 24)
• Systemic Treatment Followed by Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer (2024 · Annals of Surgery · 被引 2)
• Adjuvant therapy with donafenib plus anti–PD-1 antibody for patients (pts) with hepatocellular carcinoma (HCC) at high risk of recurrence after resection (PATH study). (2024 · Journal of Clinical Oncology · 被引 2)
• Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma (2025 · Nature · 被引 1)